Genome-scale perturb-seq in primary human CD4+ T cells maps context-specific regulators of T cell programs and human immune traits
TL;DR
By performing genome-scale perturb-seq on 22 million primary human CD4+ T cells, researchers mapped how perturbing every expressed gene alters transcriptomes in resting and stimulated states, identifying novel regulators of cytokine production and autoimmune disease risk.
Problem / question
Systematically mapping gene regulatory networks in clinically relevant human cell states is highly challenging, leaving a gap in our understanding of how specific genes control immune cell functions and contribute to disease.
Methods
The authors developed a probe-based perturb-seq platform and applied it to 22 million primary human CD4+ T cells derived from four donors. They systematically perturbed all expressed genes and measured the resulting transcriptomic changes in both resting and stimulated T cell states.
Key findings
The genome-scale screen identified novel regulators of cytokine production and demonstrated that active regulators and their target gene programs change dramatically upon T cell stimulation. By integrating these perturbation signatures with population-scale transcriptomic atlases, the authors successfully nominated specific regulators of Th1 and Th2 polarization, identified drivers of age-related T cell phenotypes, and linked context-specific regulatory pathways to autoimmune disease risk.
Why it matters
This massive single-cell perturbation dataset provides a foundational resource for decoding human immune function, interpreting genetic variation in autoimmune diseases, and modeling complex gene regulatory networks.
Limitations
The provided abstract does not explicitly detail specific limitations, caveats, or biases of the study.
Takeaway
Gene regulatory networks in human CD4+ T cells are highly dependent on the cell's stimulation context, and mapping these networks at a genome scale can directly link specific genes to immune polarization, aging, and autoimmune disease risk.